Suppr超能文献

对在精神分裂症患者中鉴定出的5-羟色胺3型受体突变的特征描述。

Characterization of 5-HT3 receptor mutations identified in schizophrenic patients.

作者信息

Thompson Andrew J, Sullivan Nora L, Lummis Sarah C R

机构信息

Department of Biochemistry, University of Cambridge, Cambridge, UK.

出版信息

J Mol Neurosci. 2006;30(3):273-81. doi: 10.1385/JMN:30:3:273.

Abstract

The 5-HT3 receptor is a member of the Cys-loop family of ligand-gated ion channels, proteins that have been implicated in the pathology of several neurological disorders. In this study, we examine two mutations (R344H and P391R) that have been previously identified in individuals diagnosed with schizophrenia. These mutations are located in the M3-M4 loop of the 5-HT3 receptor and their occurrence presents the possibility that they contribute toward the etiology of this disorder. Radioligand binding with the 5-HT receptor antagonist, [3H]granisetron, revealed no significant difference in receptor affinity or density between mutant and wild-type receptors when expressed in HEK293 cells. However, comparison of EC50 values using whole-cell patch clamp for wild-type (1.68 microM +/- 0.01, n = 38), R344H (1.70 microM +/- 0.02, n = 18), and P391R (2.73 microM +/- 0.01, n = 8) receptors revealed a significant increase in the EC50 of the P391R mutant. Analysis of Hill co-efficients, and activation and desensitization rate constants showed no significant difference between wild-type and mutant receptors. These data suggest that the P391R, but not the R344H, mutation may play a role in the pathology of schizophrenia.

摘要

5-羟色胺3(5-HT3)受体是半胱氨酸环家族配体门控离子通道的成员,这类蛋白质与多种神经疾病的病理过程有关。在本研究中,我们检测了先前在被诊断为精神分裂症的个体中发现的两种突变(R344H和P391R)。这些突变位于5-HT3受体的M3-M4环中,它们的出现表明有可能与该疾病的病因有关。用5-HT受体拮抗剂[3H]格拉司琼进行放射性配体结合实验,结果显示,在HEK293细胞中表达时,突变型受体与野生型受体在受体亲和力或密度上没有显著差异。然而,使用全细胞膜片钳技术比较野生型(1.68 microM +/- 0.01,n = 38)、R344H(1.70 microM +/- 0.02,n = 18)和P391R(2.73 microM +/- 0.01,n = 8)受体的半数有效浓度(EC50)值,发现P391R突变体的EC50显著增加。对希尔系数、激活和脱敏速率常数的分析表明,野生型受体和突变型受体之间没有显著差异。这些数据表明,P391R突变而非R344H突变可能在精神分裂症的病理过程中起作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af92/2649375/7c14ed4821c2/ukmss-3511-f0001.jpg

相似文献

引用本文的文献

9
The serotonin 5-HT3 receptor: a novel neurodevelopmental target.5-羟色胺 5-HT3 受体:一种新的神经发育靶点。
Front Cell Neurosci. 2013 May 27;7:76. doi: 10.3389/fncel.2013.00076. eCollection 2013.

本文引用的文献

2
The effect of Ondansetron on memory in schizophrenic patients.
Brain Res Bull. 2005 Apr 30;65(4):291-5. doi: 10.1016/j.brainresbull.2003.09.022.
4
GABA(A) receptor epilepsy mutations.γ-氨基丁酸A型受体癫痫突变
Biochem Pharmacol. 2004 Oct 15;68(8):1497-506. doi: 10.1016/j.bcp.2004.07.029.
6
Serotonin receptors: their key role in drugs to treat schizophrenia.血清素受体:它们在治疗精神分裂症药物中的关键作用。
Prog Neuropsychopharmacol Biol Psychiatry. 2003 Oct;27(7):1159-72. doi: 10.1016/j.pnpbp.2003.09.010.
7
Drugs which antagonize 5-hydroxytryptamine.拮抗5-羟色胺的药物。
Br J Pharmacol Chemother. 1954 Jun;9(2):240-8. doi: 10.1111/j.1476-5381.1954.tb00848.x.
10
Modulation of 5-HT3 receptor-mediated response and trafficking by activation of protein kinase C.
J Biol Chem. 2003 Sep 5;278(36):34150-7. doi: 10.1074/jbc.M303584200. Epub 2003 Jun 5.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验